Moreover, tumor expression of CD44, a hallmark of cancer cell “stemness” that promotes tumor survival and proliferation [72], was upregulated in refractory patients and depleted in the responsive ones, with higher stromal expression of one of its ligands, SPP1, in the responsive group. This evidence concerns the gene CD44 and cancer.